Payment overview · 2025
General Payments
$775.02
42 reported records · 16 companies
Healthcare provider profile · identity verified
Robert Platzman, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · PRINCETON, NJ · NPI 1497852966
Verified facts
What the public records show
CMS Open Payments records show Robert Platzman, D.O. received $775.02 in general payments during 2025 across 42 reported records.
Alpha Cognition USA, Inc. accounted for 12.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 23 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Abrysvo, Eliquis, Nuplazid, Paxlovid.
ACADIA Pharmaceuticals Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUPLAZID as an associated drug or biological on 20845 records involving 6448 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Nuplazid by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Symbicort by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 42 claims for Jardiance by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 604 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Alpha Cognition USA, Inc. | Unresolved — no canonical attribution shown | $93.30 | 12.0% | 2 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $88.12 | 11.4% | 5 | 2025 |
| Eisai Inc. | Unresolved — no canonical attribution shown | $63.00 | 8.1% | 4 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $62.08 | 8.0% | 4 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $58.66 | 7.6% | 4 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $50.17 | 6.5% | 3 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $49.25 | 6.3% | 3 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $48.89 | 6.3% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $48.23 | 6.2% | 3 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $48.06 | 6.2% | 3 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $48.04 | 6.2% | 3 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $31.47 | 4.1% | 1 | 2025 |
| C2N Diagnostics, LLC | Unresolved — no canonical attribution shown | $24.24 | 3.1% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $23.93 | 3.1% | 1 | 2025 |
| InSightec,Inc | Unresolved — no canonical attribution shown | $22.58 | 2.9% | 1 | 2025 |
| Paratek Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $15.00 | 1.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $775.02 | 42 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Zunveyl Normalized: zunveyl |
Drug | Alpha Cognition USA, Inc. | $93.30 | 2 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $88.12 | 5 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $71.97 | 4 | 2025 |
Source payment records
|
|||||
| Leqembi Normalized: leqembi |
Drug | Eisai Inc. | $63.00 | 4 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $62.08 | 4 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $62.08 | 4 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $49.25 | 3 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $48.89 | 3 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $48.23 | 3 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $48.06 | 3 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $36.56 | 2 | 2025 |
Source payment records
|
|||||
| General - DBS Normalized: general dbs |
Device | Boston Scientific Corporation | $31.47 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $29.77 | 2 | 2025 |
Source payment records
|
|||||
| PRECIVITYAD2 Normalized: precivityad2 |
Device | C2N Diagnostics, LLC | $24.24 | 1 | 2025 |
Source payment records
|
|||||
| Exablate Normalized: exablate |
Device | InSightec,Inc | $22.58 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $16.31 | 1 | 2025 |
Source payment records
|
|||||
| NUZYRA Normalized: nuzyra |
Drug | Paratek Pharmaceuticals, Inc. | $15.00 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $14.51 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $14.51 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $14.51 | 1 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $14.38 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $13.61 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $13.46 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ABRYSVO abrysvo |
2025 | Abrysvo | 2024 | 27 | exact normalized | Medicare Part D |
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 604 | exact normalized | Medicare Part D |
| NUPLAZID nuplazid |
2025 | Nuplazid | 2024 | 14 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| PAXLOVID paxlovid |
2025 | Paxlovid | 2024 | 28 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc Exact reporting entity; no affiliate inference |
2025 | NUPLAZID open payments reported associated product |
CMS Open Payments — General Payments 20845 supporting records · 6448 recipient NPIs · example record 1247763852 |
Nuplazid · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
21 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
42 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
27 | 27 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
604 | 108 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
28 | 28 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1588 | 300 |
| Amlodipine Besylate | Amlodipine Besylate | 1119 | 231 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1088 | 195 |
| Pantoprazole Sodium | Pantoprazole Sodium | 723 | 133 |
| Donepezil Hcl | Donepezil Hcl | 661 | 107 |
| Escitalopram Oxalate | Escitalopram Oxalate | 628 | 116 |
| Furosemide | Furosemide | 628 | 142 |
| Eliquis | Apixaban | 604 | 108 |
| Losartan Potassium | Losartan Potassium | 601 | 118 |
| Metoprolol Succinate | Metoprolol Succinate | 576 | 125 |
| Mirtazapine | Mirtazapine | 545 | 103 |
| Omeprazole | Omeprazole | 484 | 108 |
| Metoprolol Tartrate | Metoprolol Tartrate | 478 | 83 |
| Tamsulosin Hcl | Tamsulosin Hcl | 464 | 103 |
| Gabapentin | Gabapentin | 452 | 107 |
| Potassium Chloride | Potassium Chloride | 450 | 80 |
| Metformin Hcl | Metformin Hcl | 441 | 89 |
| Sertraline Hcl | Sertraline Hcl | 423 | 73 |
| Simvastatin | Simvastatin | 398 | 68 |
| Quetiapine Fumarate | Quetiapine Fumarate | 390 | 73 |
| Lisinopril | Lisinopril | 385 | 71 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 354 | 81 |
| Trazodone Hcl | Trazodone Hcl | 342 | 84 |
| Alprazolam | Alprazolam | 325 | 86 |
| Tramadol Hcl | Tramadol Hcl | 319 | 75 |
| Divalproex Sodium | Divalproex Sodium | 313 | 54 |
| Xarelto | Rivaroxaban | 306 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 300 | 56 |
| Memantine Hcl | Memantine Hcl | 290 | 55 |
| Carvedilol | Carvedilol | 259 | 44 |
| Famotidine | Famotidine | 258 | 64 |
| Warfarin Sodium | Warfarin Sodium | 227 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 204 | 34 |
| Duloxetine Hcl | Duloxetine Hcl | 203 | 30 |
| Olanzapine | Olanzapine | 202 | 34 |
| Latanoprost | Latanoprost | 197 | 39 |
| Lorazepam | Lorazepam | 192 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 191 | 47 |
| Hydralazine Hcl | Hydralazine Hcl | 184 | 38 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 168 | 104 |
| Midodrine Hcl | Midodrine Hcl | 167 | 42 |
| Risperidone | Risperidone | 164 | 18 |
| Prednisone | Prednisone | 159 | 44 |
| Finasteride | Finasteride | 149 | 35 |
| Pravastatin Sodium | Pravastatin Sodium | 143 | 28 |
| Buspirone Hcl | Buspirone Hcl | 140 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 139 | 31 |
| Montelukast Sodium | Montelukast Sodium | 138 | 29 |
| Levetiracetam | Levetiracetam | 128 | 21 |
| Azithromycin | Azithromycin | 126 | 98 |
| Fluticasone Propionate | Fluticasone Propionate | 120 | 35 |
| Methenamine Hippurate | Methenamine Hippurate | 118 | 18 |
| Lansoprazole | Lansoprazole | 117 | 28 |
| Ezetimibe | Ezetimibe | 116 | 25 |
| Clonazepam | Clonazepam | 113 | 22 |
| Meloxicam | Meloxicam | 109 | 22 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 108 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 106 | 18 |
| Valsartan | Valsartan | 106 | 20 |
| Bumetanide | Bumetanide | 105 | 23 |
| Allopurinol | Allopurinol | 103 | 26 |
| Spironolactone | Spironolactone | 102 | 22 |
| Zolpidem Tartrate | Zolpidem Tartrate | 101 | 29 |
| Glimepiride | Glimepiride | 100 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 94 | 21 |
| Lamotrigine | Lamotrigine | 91 | 12 |
| Atenolol | Atenolol | 90 | 20 |
| Nystatin | Nystatin | 90 | 32 |
| Amiodarone Hcl | Amiodarone Hcl | 89 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 86 | 32 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 85 | 52 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 84 | 12 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 83 | 15 |
| Memantine Hcl Er | Memantine Hcl | 80 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 78 | 15 |
| Digoxin | Digoxin | 78 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 77 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 77 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 76 | 40 |
| Alendronate Sodium | Alendronate Sodium | 75 | 15 |
| Aripiprazole | Aripiprazole | 75 | 15 |
| Divalproex Sodium Er | Divalproex Sodium | 75 | 11 |
| Metformin Hcl Er | Metformin Hcl | 75 | 15 |
| Irbesartan | Irbesartan | 73 | 16 |
| Lacosamide | Lacosamide | 72 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 70 | 17 |
| Breo Ellipta | Fluticasone/Vilanterol | 69 | 12 |
| Ramipril | Ramipril | 69 | 15 |
| Bupropion Xl | Bupropion Hcl | 68 | 17 |
| Insulin Lispro | Insulin Lispro | 68 | 13 |
| Procrit | Epoetin Alfa | 65 | suppressed |
| Topiramate | Topiramate | 65 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 64 | 18 |
| Enalapril Maleate | Enalapril Maleate | 63 | suppressed |
| Januvia | Sitagliptin Phosphate | 63 | 11 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 62 | 17 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 62 | 23 |
| Ondansetron Hcl | Ondansetron Hcl | 62 | 32 |
| Pregabalin | Pregabalin | 60 | 15 |
| Sucralfate | Sucralfate | 60 | suppressed |
| Methylprednisolone | Methylprednisolone | 57 | 47 |
| Baclofen | Baclofen | 56 | 12 |
| Cephalexin | Cephalexin | 55 | 45 |
| Lactulose | Lactulose | 54 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 53 | 13 |
| Rivastigmine | Rivastigmine Tartrate | 52 | 11 |
| Verapamil Er | Verapamil Hcl | 52 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 51 | suppressed |
| Torsemide | Torsemide | 51 | 12 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 51 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 50 | 11 |
| Clonidine Hcl | Clonidine Hcl | 49 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 48 | 41 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 48 | 39 |
| Misoprostol | Misoprostol | 48 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 48 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 47 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 45 | suppressed |
| Novolog | Insulin Aspart | 45 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 45 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 45 | 12 |
| Tradjenta | Linagliptin | 45 | 11 |
| Amoxicillin | Amoxicillin | 43 | 26 |
| Entresto | Sacubitril/Valsartan | 43 | suppressed |
| Repaglinide | Repaglinide | 43 | suppressed |
| Hydrocortisone | Hydrocortisone | 42 | 19 |
| Jardiance | Empagliflozin | 42 | suppressed |
| Clobazam | Clobazam | 41 | suppressed |
| Myrbetriq | Mirabegron | 41 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 40 | 11 |
| Metolazone | Metolazone | 38 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 36 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 36 | suppressed |
| Celecoxib | Celecoxib | 36 | 13 |
| Ipratropium Bromide | Ipratropium Bromide | 36 | 16 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 35 | 34 |
| Glipizide | Glipizide | 35 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 35 | suppressed |
| Phenobarbital | Phenobarbital | 34 | suppressed |
| Creon | Lipase/Protease/Amylase | 33 | suppressed |
| Chlorthalidone | Chlorthalidone | 32 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 32 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 32 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 32 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 31 | suppressed |
| Levofloxacin | Levofloxacin | 31 | 23 |
| Rivastigmine | Rivastigmine | 31 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 31 | 24 |
| Budesonide | Budesonide | 30 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 30 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 30 | suppressed |
| Dutasteride | Dutasteride | 30 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | 11 |
| Heparin Sodium | Heparin Sodium,porcine | 28 | suppressed |
| Levemir | Insulin Detemir | 28 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 28 | 26 |
| Paxlovid | Nirmatrelvir/Ritonavir | 28 | 28 |
| Synthroid | Levothyroxine Sodium | 28 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 27 | 27 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 27 | suppressed |
| Colchicine | Colchicine | 26 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 26 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 26 | 12 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 25 | suppressed |
| Carbamazepine | Carbamazepine | 25 | suppressed |
| Folic Acid | Folic Acid | 25 | 13 |
| Lovastatin | Lovastatin | 25 | suppressed |
| Methotrexate | Methotrexate Sodium | 25 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 16 |
| Armour Thyroid | Thyroid,pork | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Calcium Acetate | Calcium Acetate | 23 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 23 | suppressed |
| Briviact | Brivaracetam | 22 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 22 | suppressed |
| Gemtesa | Vibegron | 22 | suppressed |
| Mupirocin | Mupirocin | 22 | 15 |
| Ammonium Lactate | Ammonium Lactate | 21 | 14 |
| Calcitriol | Calcitriol | 21 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Fycompa | Perampanel | 21 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 21 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Fentanyl | Fentanyl | 20 | suppressed |
| Fluconazole | Fluconazole | 20 | 12 |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 19 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 19 | 19 |
| Naproxen | Naproxen | 19 | suppressed |
| Ozempic | Semaglutide | 19 | suppressed |
| Timolol Maleate | Timolol Maleate | 19 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 18 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 18 | suppressed |
| Dextrose 5%-0.9% Nacl | Dextrose 5 % And 0.9 % Nacl | 18 | suppressed |
| Eszopiclone | Eszopiclone | 18 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 18 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 18 | suppressed |
| Klor-Con M20 | Potassium Chloride | 18 | suppressed |
| Levemir Flexpen | Insulin Detemir | 18 | suppressed |
| Methimazole | Methimazole | 18 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 18 | suppressed |
| Amiloride-Hydrochlorothiazide | Amiloride/Hydrochlorothiazide | 17 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Nystop | Nystatin | 17 | 11 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 16 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 16 | 11 |
| Sps | Sodium Polystyrene Sulfon/Sorb | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Voriconazole | Voriconazole | 16 | suppressed |
| Alogliptin | Alogliptin Benzoate | 15 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Clozapine | Clozapine | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Demeclocycline Hcl | Demeclocycline Hcl | 14 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 14 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Admelog | Insulin Lispro | 13 | suppressed |
| Admelog Solostar | Insulin Lispro | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Mresvia | Rsv Vaccine, Pref, Mrna/Pf | 13 | 13 |
| Olanzapine Odt | Olanzapine | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 13 | 13 |
| Oxycontin | Oxycodone Hcl | 13 | suppressed |
| Pancreaze | Lipase/Protease/Amylase | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 12 | suppressed |
| Epogen | Epoetin Alfa | 12 | suppressed |
| Fluorometholone | Fluorometholone | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Lorazepam Intensol | Lorazepam | 12 | 12 |
| Nabumetone | Nabumetone | 12 | suppressed |
| Nyamyc | Nystatin | 12 | suppressed |
| Paroxetine Er | Paroxetine Hcl | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate | 12 | suppressed |
| Xifaxan | Rifaximin | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Galantamine Er | Galantamine Hbr | 11 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 11 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Nateglinide | Nateglinide | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Risperidone Odt | Risperidone | 11 | suppressed |
| Ssd | Silver Sulfadiazine | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
| Viberzi | Eluxadoline | 11 | suppressed |
| Vraylar | Cariprazine Hcl | 11 | suppressed |
| Vyvanse | Lisdexamfetamine Dimesylate | 11 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $775.02 · 42 records | Alpha Cognition USA, Inc. | ABRYSVO, AIRSUPRA, CAPLYTA, COMIRNATY, Cologuard Collection Kit, ELIQUIS, Exablate, General - DBS, Kerendia, Leqembi, MOUNJARO, NUPLAZID, NURTEC ODT, NUZYRA, OTEZLA, PAXLOVID, PRECIVITYAD2, PREVNAR 20, REPATHA, REXULTI, ZAVZPRET, ZEPBOUND, Zunveyl | 7 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Abrysvo play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ACADIA Pharmaceuticals Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error